MYO Rapid Quantitative Test
- UID
- IMP/IVD/2022/000074_a4d0cbfa853c6a7151be5c120aa62465_f055cba82f4e923d34eb5876e758d1f3
- Device class
- Class B
- Brand name
- Glycated Hemoglobin
- License holder
- FINOVA HEALTHCARE PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- The Aehealth Myo Rapid Test along with Aehealth Fluorescence Immunoassay Analyzer (Glycated Hemoglobin) is a fluorescence immunoassay for quantitative measurement of Myoglobin (Glycated Hemoglobin) in human whole blood, serum or plasma,25-(Glycated Hemoglobin)-VD (Glycated Hemoglobin) Rapid Quantitative Test (Glycated Hemoglobin)(Glycated Hemoglobin)-The 25-（OH）VD Rapid Quantitative Test along with AEHEALTH FIA Meter is intended for vitro quantitative determination of 25-（OH）VD in human serum or plasma, it is mainly used for the auxiliary diagnosis of vitamin D deficiency related diseases
MYO Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_a4d0cbfa853c6a7151be5c120aa62465_f055cba82f4e923d34eb5876e758d1f3. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.